With Global Horizon, Chinese Angle strategy, BOCG strives to support true innovation and disruptive technology of life science.
Accumulated 100+ years’ experience and US$ 1+ billion proven record, the BOCG veteran team builds its office and franchise in Shenzhen, Shanghai, Hong Kong, and Gothenburg of Sweden, and extensive networks and footprint in Greater China, Asia, USA and Europe.
A signatory to the UN PRI and committed to promoting sustainable development and impact investment.
Shenzhen, China – June 16, 2026 – The launch ceremony of the 2026 AI Brain-Computer Interface (BCI) Global Challenge and NeuroHub Accelerator took place at the Shenzhen Brain Science and Technology Industry Innovation Center.
SHENZHEN, China – May 29, 2026 – Blue Ocean Capital officially celebrated the relocation of its headquarters to Guangming Science City today, hosting a landmark event that integrated cutting-edge brain science with contemporary art.
The 25th Greater China Private Equity Summit concluded successfully in Hong Kong on May 19, bringing together over 650 participants, with more than 60 speakers exploring industry trends and emerging opportunities across the region.Frank Yang, Founding Partner and CEO of Blue Ocean Capital Group (“BOCG”), chaired the biotech roundtable, where leading global investment experts engaged in in-depth discussions on cutting-edge biotech developments and cross-border investment strategies.
